Slideshow
Author(s):
These medical apps provided technology for caregivers to track symptoms, make appointments with doctors, monitor medications, and more.
GLP-1 Agonists and SGLT2 Inhibitors Considered More Effective for Lowering Alzheimer Disease Risk
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
How Personalized Repetitive Transcranial Magnetic Stimulation May Transform Alzheimer Treatment
Neurology Unwrapped: 2024’s Most Intriguing Conversations
A New Era in Research: Exploring Cognitive Health and Alzheimer Disease in Down Syndrome
NeurologyLive® Friday 5 — April 11, 2025